Brief: Optimizerx Corp Enters Amendment No. 4 To Financing Agreement- SEC Filing
05/03/2026 22:09
March 5 (Reuters) - SEC Filing: OPTIMIZERX CORP - ENTERS AMENDMENT NO. 4 TO FINANCING AGREEMENT ON MARCH 2, 2026 - SEC FILING OPTIMIZERX CORP - EXTENDS MATURITY DATE OF FINANCING AGREEMENT TO OCTOBER 11, 2029 - SEC FILING OPTIMIZERX CORP - PERMITS REPURCHASE OF UP TO $10 MILLION IN COMMON STOCK BEFORE MARCH 15, 2027 - SEC FILING Source text: [ID:n0001448431-26-000002] Further company coverage: OPRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on OptimizeRx
See all newsBrief: Optimizerx Announces Finance Leadership Appointments To Support The Next Phase Of Growth
OptimizeRx Corporation reports results for the quarter ended June 30 - Earnings Summary
OptimizeRx Q2 revenue beats estimates on operating resilience; reaffirms outlook
OptimizeRx Corporation expected to post earnings of 12 cents a share - Earnings Preview
Brief: Optimizerx Corp - Enters Credit Agreement With Fifth Third Bank On May 7, 2026 - SEC Filing